Aquestive Therapeutics, Inc. Common Stock (AQST) is a publicly traded Healthcare sector company. As of September 11, 2026, AQST trades at $4.86 with a market cap of $646.38M and a P/E ratio of -7.61. AQST moved -3.01% today. Year to date, AQST is -22.64%; over the trailing twelve months it is +2.25%. Its 52-week range spans $2.12 to $7.55. Analyst consensus is strong buy with an average price target of $9.00. Rallies surfaces AQST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest AQST news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.86 |
| Market Cap | $646.38M |
| P/E Ratio | -7.61 |
| EPS | $-0.66 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.55 |
| 52-Week Low | $2.12 |
| Volume | 2.30M |
| Avg Volume | 0 |
| Revenue (TTM) | $54.09M |
| Net Income | $-78.23M |
| Gross Margin | 67.04% |
5 analysts cover AQST: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.00.